With the skin and special senses, the gastrointestinal tract is unique in its exposure to the changes and vicissitudes of the external environment. However, fine control of all aspects of gut function via neuronal and endocrine mechanisms is essential for adequate nutrition through digestive and absorptive processes. Recent chemical studies have resulted in the isolation and elucidation of a wide range of biologically active gut peptides. The gastrointestinal tract is the largest endocrine organ of the body and regulates carbohydrate metabolism (the entero-insular axis) in addition to protein and fat metabolism. Disturbance of gut function by any disease process is therefore likely to have profound consequences on metabolic and nutritional processes, in addition to acid-base and fluid balance.
Clearly, it is beyond the scope of a single chapter to present a comprehensive clinical review of this subject. Emphasis will be placed only on malnutrition, maldigestion and malabsorption, whilst obesity-a heterogenous process in which the gut undoubtedly plays a role-will not be discussed. Consideration of treatment may appear to be brief, but the vast subjects of enteral and parenteral nutrition are outside the present remit.
FLUID AND METABOLIC ABNORMALITIES

Water and electrolytes
Gastrointestinal disease leads predominantly to deficiencies in water and electrolytes. Methods of calculating water and electrolyte deficiencies are summarized in table I. Many of these deficiencies occur synchronously and are inter-related, and consideration of individual deficiencies is artefactual. Water balance is related intimately to sodium balance, and alterations in plasma or total body chloride and potassium are often associated with acid-base disturbances. Water. The oesophageal and gastric mucosae are relatively impermeable to bulk water flow and so the body is protected from the widely diverse tonicity of fluids taken orally. Osmoreceptors in the duodenum detect hypertonic solutions and slow gastric emptying into the proximal small bowel, which is highly permeable to bulk water flow and sodium chloride. By the time the small bowel contents have reached the terminal ileum, the osmolality and sodium concentration are close to those of plasma. Finally, the colon actively absorbs water and sodium and secretes small amounts of potassium.
When 2% of body weight has been lost as water, thirst and antidiuretic hormone (ADH) secretion are stimulated. However, since water is freely permeable across cell membranes, it is lost from both extracellular and intracellular fluid compartments, and plasma volume is maintained initially Peripheral circulatory failure resulting from pure Normal body water -0.6 x (body wt) (kg) Present body water = (normal plasma Na (140)) x (normal body water) (present plasma Na) water loss is a very late manifestation. As water depletion continues, the colloid osmotic pressure of the intravascular compartment helps maintain its volume, so that only 12% of the total water loss occurs in this compartment. The gastrointestinal causes of pure water loss are shown in table II, with clinical features and biochemical changes. Carcinoma of the oesophagus, vomiting before or after operation and surgical "nil by mouth" regimens are all common causes in patients on surgical wards.
After calculation (table I) , the water deficiency should be replaced over a period of 2-3 days.
Sodium. The permeability of the small bowel to salt and water usually causes synchronous losses and, clinically, combined losses are most common (table III) . In contrast to pure water loss, salt loss and reduced plasma sodium can reduce thirst and ADH secretion, and plasma sodium concentration is preserved primarily at the expense of extracellular fluid (ECF) volume. Thus, changes in plasma sodium are proportional to ECF sodium and reflect total ECF water. The pathophysiology of the changes in sodium balance found in vomiting, diarrhoea, intestinal obstruction and pancreatitis are considered in greater detail below. Replacement with fluid depends largely on the nature of the fluid lost and usually Hartmann's solution is the most appropriate for gastrointestinal loss (table I) .
Chloride. Losses of chloride occur in the same circumstances as hyponatraemia. In the gastrointestinal tract they usually result from loss of gastric juice by vomiting secondary to pyloric stenosis or prolonged nasogastric suction. Replacement should be with 0.9% sodium chloride. Hyperchloraemia occurs in dehydration and in the special circumstances of a uretero -ileostomy or -colostomy, when it is associated with metabolic acidosis. Whilst it is possible to calculate the chloride deficit (table I) , it is more usual to correct the underlying cause and the associated sodium abnormality.
Potassium. Hypokalaemia is important not only because it induces tachycardia, hypotension and cardiac arrhythmias, but also because of a paralytic effect on gastrointestinal motility. This may delay recovery of normal bowel function following abdominal surgery and may cause further potassium losses through vomiting, malabsorption and con- Calcium. There are relatively few gastrointestinal diseases which disturb calcium metabolism (table  V) . Malabsorption of vitamin D may occur in any condition, causing steatorrhoea. Demineralization of the skeleton after partial gastrectomy is common and associated with increased excretion of faecal fat (Eddy, 1971) . Extensive bowel resection leads to both calcium and magnesium deficiencies. In clinical practice it is more usual to find hypocalcaemia following sequestration of calcium in dead tissues and exudates associated with acute pancreatitis and generalized peritonitis. In addition to oral supplementation with vitamin D, marked hypocalcaemia may require an i.v. infusion of calcium; the chloride salt is probably more reliably ionized and predictable in effect than calcium gluconate. An i.v. infusion of up to 5 mmol 8-hourly is probably safer than an i.v. bolus dose.
TABLEIII. Gasxrointtstinal causes of hyponatraemia
Causes
It is worth mentioning here that, paradoxically, hypercalcaemia often causes severe gastrointestinal Other elements. Iron deficiency anaemia may occur in any debilitated surgical patient with a poor appetite, chronic blood loss or gastrointestinal disease and is one of the commonest causes of anaemia, especially in women after partial gastrectomy (Tovey and Clark, 1980) . A low zinc status is frequent in cirrhosis, malabsorption and chronic pancreatitis. There have been single case reports of selenium deficiency associated with inflammatory bowel disease and chromium deficiency following complete enterectomy and prolonged total parenteral nutrition. Deficiency of other essential elements such as copper, cobalt and manganese has not been reported to be of special significance in surgical patients.
Acid-base. The main abnormality of acid-base balance in gastrointestinal disease arises from loss of bicarbonate from the gut, producing metabolic acidosis. Bicarbonate may be lost from pancreatic, biliary or small bowel fistulae. Patients with diarrhoea, a uretero-enterostomy, or receiving cholestyramine may also suffer excessive losses of bicarbonate. The small intestine is equipped throughout with a highly efficient sodium-hydrogen exchange mechanism for the absorption of pancreatic bicarbonate, whilst the ileum and colon absorb chloride in exchange for bicarbonate.
Metabolism
The fundamental nutritional requirements for protein, carbohydrate, fat, vitamins and minerals are affected by a variety of factors which (in addition to disease) include growth rate, physical activity and climate. Disorders in protein and energy metabolism may be caused by hypermetabolic states related, for example, to extensive surgery, sepsis and advanced gastrointestinal cancer. Excessive losses of fluids may occur in gastrointestinal fistulae (Kominsky and Dietel, 1975) or abscesses and acute pancreatitis (Blackburn et al., 1976) . Finally, gastrointestinal disease may lead to maldigestion, malabsorption and subsequent malnutrition. Disorders of metabolism often result from a combination of one or more of these factors.
Protein and calories. The features of malnutrition associated with maldigestioii and malabsorption are considered in more detail in the section on pathophysiology (below). It has been recognized for some time that patients with malnutrition have a poorer outcome after surgery (Lawson, 1965) .
Therapy involves parenteral and enteral nutrition. Although this is a controversial area, there is little evidence to support the contention that correcting protein and calorie malnutrition significantly improves mortality and morbidity in patients with gastrointestinal disease. However, parenteral nutrition may be helpful in patients treated by radiotherapy for cancer of the gastrointestinal tract (Copeland et al., 1975) and there is a trend towards reduced mortality and morbidity in patients with carcinoma of the oesophagus receiving parenteral nutrition (Moghissi et al., 1977) . Parenteral nutrition has been reported to reduce the mortality and increase spontaneous closure of small intestinal fistulae (Himal et al., 1974) .
Fats. Steatorrhoea may follow resection of the ileum or terminal ileum and to a milder degree after gastroenterotomy or vagotomy (Losowsky, Walker and Kelleher, 1974) . Essential fatty acid deficiency may occur in patients with carcinoma of the oesophagus (Wapnick, Norden and Venturas, 1974) and after extensive gut resection (Press, Hartop and Prottey, 1974) .
Vitamins. Any fat-soluble vitamins may be malabsorbed in steatorrhoea, and vitamin A deficiency has been reported after total gastrectomy (Adams, Johnstone and Hunter, 1960) . Gastrectomy also leads to an absence of intrinsic factor and, after several years, vitamin B^ deficiency may develop. Deficiency of this vitamin is also common in the blind loop syndrome, from bacterial colonization of the loop, but is a less frequent cause of megaloblastic anaemia in Crohn's disease than folic acid deficiency. Folic acid deficiency and megaloblastic anaemia may also be long-term sequelae of gastrectomy and Crohn's disease. Vitamin C absorption may be impaired in patients undergoing vagotomy for peptic ulcer secondary to decreased gastric acid secretion (Macdonald and Cohen, 1972) .
Effects on bowel function. The absence of nutrient from the lumen of the small intestine, whether the patient is receiving parenteral nutrition or not, results in a decrease in mucosal mass and absorptive function, particularly in the jejunum. These effects are not fully understood but may involve substrate absorption, specific effects of bile and pancreatic secretions, trophic influences of gut hormones, intestinal blood flow, and innervations. Chronic protein malnutrition has been reported to produce mor-phological and functional abnormalities in the small intestine (James, 1968; Herskovic, 1969) . Pancreatic abnormalities from protein-calorie malnutrition may be common in anorexia nervosa and must be differentiated from primary pancreatitis (Cox ct al., 1983) . Furthermore, selective nutrient deficiencies such as from vitamin B12 may also alter intestinal histology and mucosal function (Lindenbaum, Pezzimenti and Shea, 1974) .
PATHOPHYSIOLOGY
Disorders of function
Anorexia. Nausea and anorexia, particularly when related to gastrointestinal disease, may cause a significant reduction in protein-calorie intake. These symptoms, together with weight loss, are often the symptom presenting to the clinician. Anorexia is an important differential diagnostic feature, since it is nearly always found in generalized small bowel diseases, but is unusual in pancreatic insufficiency related to chronic pancreatitis or cystic fibrosis. It is the maintenance of appetite in these latter conditions which contributes, in a large degree, to the extent of steatorrhoea.
Vomiting. Vomiting may be an early feature of upper gastrointestinal disease, including obstruction, peritonitis, cholecystitis or pancreatitis. Large amounts of hydrogen, chloride, potassium and sodium ions may be lost, resulting in reduced plasma concentrations, and loss of acid causes metabolic alkalosis. This, together with loss of potassium ions in the vomitus, compounded by decreased food intake, causes potassium deficiency, and a shift of hydrogen ions into cells exacerbates alkalosis. It has been mentioned above that loss of sodium ions causes early reduction in ECF volume and further worsening of the metabolic alkalosis. Sodium deficiency and increased plasma bicarbonate concentrations lead to renal compensation with further urinary loss of sodium and potassium. If the vomiting persists, starvation causes catabolism with ketosis and increased blood urea concentration.
Diarrhoea. Diarrhoea causes salt, water and potassium depletion together with acid-base disturbances. If salt and water are lost in isotonic proportions, there is a contraction of ECF volume and haemoconcentration. Although the serum sodium is normal, if the salt loss is not replaced adequately there is an increased secretion of ADH. The retained water is then distributed throughout the total body water and there may be hyponatraemia. If there is an osmotic cause for the diarrhoea, proportionately more water is lost and dehydration with hypernatraemia may occur. Thus, the ECF compartment is expanded at the expense of the ICF space and severe thirst results. Potassium depletion often occurs in longstanding mild diarrhoea states, including chronic laxative abuse (Schwartz and Relman, 1953) . Intestinal juice contains more bicarbonate than chloride, so that plasma bicarbonate is more reduced than chloride and a metabolic acidosis occurs. Bacterial action on intestinal contents with the release of organic acids renders direct measurement of stool pH and bicarbonate concentration of no value in predicting the disturbances in acid-base balance. Diarrhoeal stools may have a low bicarbonate concentration and a low pH, yet the patient may exhibit net loss of base from the body and develop systemic acidosis. The acid-base picture is further complicated by the secondary effects of hypokalaemia, starvation, shock and any renal impairment. An exudative diarrhoea leads to increased protein loss (see Inflammatory Bowel Disease, below).
Intestinal obstruction. The metabolic and fluid consequences of obstruction depend on the nature and site of the obstruction. In high gastrointestinal obstruction the losses are mainly of gastric juice and the sequelae are described above. In addition to water losses through vomiting, the obstructed bowel may contain large volumes of sequestrated water, not only within the lumen, since distension increases intestinal secretion of water and electrolytes in the obstructed segment, but also in the form of oedema of the bowel wall and mesentery. Finally, free peritoneal fluid may collect as a result of transudation of water from the bowel. This intestinal distension is more a feature of distal small bowel obstruction and paralytic ileus. Despite the loss of fluid into the bowel, the abnormalities of serum electrolytes are usually less dramatic. There may be oliguria, uraemia and haemoconcentration. The circulatory changes of tachycardia, reduced cardiac output and hypotension are late features. Strangulation, perforation and peritonitis may add the features of septic or toxic shock to the metabolic picture.
Colonic obstruction produces less fluid and electrolyte disturbance than small bowel obstruction and the losses are more frequently those of diarrhoea. Inflammation and congestion of the obstructed bowel may lead to loss of protein.
Maldigestion and malabsorption. Malnutrition may result first from maldigestion-failure of the intraluminal phase of digestion of fats, protein and carbohydrate. This mainly involves gastric, pancreatic and biliary exocrine function. Second, failure may occur at the epithelial surface, the cellular layer or in the removal of the products of digestion in the lymphatics or blood stream-malabsorption. The early symptoms in a patient with abnormal digestive-absorptive processes may be subtle. Bowel habit may change before the onset of weight loss, pain, anorexia, or the gross changes of greasy, bulky, foul-smelling stools. If the early complaints are overlooked, the patient progresses to the stage of classical malnutrition and cachexia. The clinical features, laboratory findings and pathophysiological processes involved in these syndromes are summarized in table VII. The overall effects of malabsorption are a combination of starvation and dehydration. In addition to increased losses and decreased absorption of proteins, carbohydrates and fats there are deficiencies of fat-soluble vitamins A, D, E and K. In severe cases, there is an increase in the obligatory loss of sodium into the stool, which contributes to the osmotic diarrhoea in the malabsorption syndrome. The osmotic loss of other non-absorbable solutes with excess sodium loss occasionally produces an increase in serum sodium, but more commonly the syndrome is that of hyponatraemia, hypokalaemia with a reduction in circulating and ICF volumes and a metabolic acidosis. A great many individual diseases produce maldigestion and malabsorption according to the major site of the defective function (table VIII) . Each produces typical results in clinical and laboratory tests which are too various to detail.
Malnutrition and cancer
The metabolic abnormalities and malnutrition associated with malignancy are manifold (table IX) . In addition to systemic effects of "tumour cachexia", direct involvement of the gastrointestinal tract by tumour may cause anorexia, nausea, vomiting, diarrhoea, fistula formation, strictures or frank intestinal obstruction. Considerable fluid, metabolic and nutritional disturbances may result from surgery, radiotherapy or chemotherapy of the malignant disease and these are considered below. Surgery. Operations on any part of the gastrointestinal tract from the mouth to the anus may disturb function and cause nutritional deficiencies. Surgery of the head and neck can result in difficulties with chewing or swallowing. Partial or subtotal oesophagectomy is accompanied by vagotomy which may produce malabsorption, delayed gastric emptying and diarrhoea. Vagotomy and drainage, partial, subtotal, or total gastrectomy may cause the "small stomach syndrome" with early satiety and decreased caloric intake. Post-cibal dumping with either early hypovolaemia or late hypoglycaemia can occur. Subsequent steatorrhoea leads to vitamin B 12 deficiency. More serious long-term nutritional problems are experienced after massive small bowel resection and in recent years home parenteral nutrition has been used with considerable success. Pancreatic enzyme supplements and insulin may be required after partial or total pancreatectomy. Finally, patients with stomata, particularly ileostomies, may exhibit serious fluid and electrolyte disorders which require massive replacement.
Radiotherapy. Radiation of the gastrointestinal tract causes a variety of disturbances. In the acute phase, radiation sickness may lead to nausea, vomiting and diarrhoea. In the long-term, nutritional problems may arise from loss of teeth, stomatitis, oesophagitis and strictures of the oesophagus or small bowel, and partial or complete obstruction Drug treatment. Many drugs cause malabsorption and this possibility should always be borne in mind when examining a patient with suspected malabsorption. Cholestyramine binds bile acids, causing steatorrhoea with malabsorption of fat-soluble vitamins. Aluminium-based antacids which also contain magnesium may increase faecal loss of calcium secondary to the increased stool volume effected by magnesium (Spencer et al., 1982) . Aluminiumcontaining antacids combine with phosphorus in the gut and a decreased serum phosphorus concentration from decreased intestinal absorption increases urinary calcium excretion (Spencer and Kramer, 1983) . Aluminium hydroxide also chelates iron and prevents absorption. Malabsorption may also occur with neomycin, colchicine and anticonvulsant drugs. Hormones and chcmotherapeutic agents can cause a reduction in appetite, increased tissue catabolism and inhibition of cell proliferation, all of which may lead to serious nutritional deficiencies.
GASTROINTESTINAL DISEASES
The first two sections of this article have summarized many of the gastrointestinal diseases associated with metabolic and fluid abnormalities, but some specific diseases deserve more detailed consideration.
Obstruction of the oesophagus by either a benign or malignant stricture is one of the few conditions characterized by pure water deficiency and proteincalorie malnutrition. In carcinoma of the oesophagus, additional features of malnutrition may occur from extra-gastrointestinal effects of the cancer.
Menetrier's disease, giant hypertrophic gastritis, is an uncommon condition characterized by massive enlargement of the gastric mucosal folds by hyperplastic surface mucouscells. This was the first condition in which a protein-losing gastroenteropathy was identified (Gtrin, Sterling and Halsted, 1957) . Parietal cells may be reduced in number with consequent diminution in gastric acid secretion or even achlorhydria and the gastric juice may contain excessive amounts of plasma proteins. These increased intraluminal losses of plasma protein may lead eventually to hypoproteinaemia and oedema. Chronic atrophic gastritis is also associated with a reduction in the number of parietal cells, and oxyntic cells, and the replacement of gastric glands by undifferentiated or pyloric-type cells. Usually, intrinsic factor is secreted in considerable excess of the amount necessary for optimal vitamin B 12 absorption, but atrophic gastritis and the associated achlorhydria may cause vitamin B u malabsorption. This, together with hypergastrinaemia, is characteristic of patients with pernicious anaemia and may also be associated with diabetes mellitus. It is interesting that the lack of pepsinogen secretion by the oxyntic (chief) cells is not sufficiently important to produce protein maldigestion-because of the adequacy of other intestinal peptidases.
Large villous adenomas may occur at any site in the bowel, but are most common in the rectum and lead to a clinical syndrome of water and electrolyte loss from perfused secretion of watery mucus with consequent hypovolaemia, hypokalaemia and proteinlosing enteropathy.
Pancreatic Diseases Pancreatitis
Acute. In the more severe forms of acute pancreatitis, autodigestion of the gland releases several cytotoxic substances which probably both initiate and potentiate further damage to the gland. Trypsin produces oedema, liquefaction, necrosis and haemorrhage. Chymotrypsin produces oedema and haemorrhage, whilst kaUikrein adds to the oedema, and elastase to the haemorrhage. Phospholipase A and lipase cause pancreatic and fat necrosis. The metabolic consequences of these changes are compounded by nausea, vomiting, fever, jaundice and ileus. The shock syndrome may be hypovolaemic, haemorrhagic or septic, or a combination. The other pathological features of metabolic importance include hypocalcaemia, hyperglycaemia, hyperlipidaemia and hypoxia. In the early stages of the disease the main therapeutic aims are to maintain an adequate circulating fluid volume, and hence renal function, in addition to correction of abnormalities of calcium and glucose.
Chronic. Chronic pancreatitis is associated with permanent destruction of pancreatic tissue and may result in exocrine or endocrine pancreatic insufficiency, or both. The pancreas has a large functional reserve and exocrine insufficiency does not occur until 90% of the gland's secretory capacity is lost (DiMagno, Go and Summerskill, 1973) . Malabsorption with steatorrhoea is characteristic, but carbohydrate metabolism is not severely affected as a result of the presence of salivary amylase. Clinical deficiencies of fat-soluble vitamins are rare even with marked steatorrhoea, because bile secretion is normal and lipid soluble vitamins depend on bile more than on pancreatic juice for absorption. Clinically significant vitamin B 12 deficiency is also unusual. Approximately one-third of patients with chronic pancreatitis have frank diabetes mellitus and another 30% have abnormal glucose tolerance (Sarles and Gerolami-Santandrea, 1972) . The diabetes is usually mild and easily controlled with insulin. By the time diabetes is evident there is usually some degree of malabsorption.
Endocrine tumours
The physiological and pathophysiological importance of many of the newly-discovered gut peptides and amines have yet to be established. Glucagon, insulin-releasing polypeptide (IRP) and glucosedependent insulinotropic peptide (GIP) all interact in the enteroinsular axis (Marks and Turner, 1977) . These cells belong to the APUD series (Pearse, 1969) and tumours affecting these cells are known as apudomas. The apudomas may be classified as orthoendocrine when they secrete the normal polypeptide or amine hormones of their cells of origin, or paraendocrine, secreting hormones which are characteristic of other endocrine cells. Secretory tumours of the pancreas can affect the B, A, D or PP cells of the pancreatic islets and form insulinomas, glucagonomas, somatostatinomas and PP-omas respectively. Vipomas almost certainly arise from neural tissue.
Insulinoma. Patients characteristically suffer from Whipple's triad of nervous or gastrointestinal disturbance, occurring in the fasting state, associated with hypoglycaemia and relieved immediately by oral or i.v. glucose. Hyperinsulinism exists in the presence of hypoglycaemia. Prolonged fasting for up to 48 h may be necessary to establish a diagnosis.
Glucagonoma. This tumour is characterized by a migratory determatitis, painful glossitis, angular stomatitis, mild anapmia, diabetes, loss of weight and occasionally diarrhoea. It is interesting that the determatitis often responds to treatment with zinc, suggesting that zinc deficiency may play some part in the pathogenesis of this syndrome (Mallinson et al., 1977) .
Somatostatinoma. Only two cases have been described in which somatostatin appeared to be the sole peptide product. Possible features of the syndrome include diabetes, hypochlorhydria and steatorrhoea (Ganda et al., 1977; Larsson et al., 1977) .
Vipoma. These tumours cause watery diarrhoea, hypokalaemia and achlorhydria or hypochlorhydria (the WDHA syndrome or pancreatic cholera)-described by Verner and Morrison in 1974. The full clinical and pathological significance of these tumours has been established in the large series of patients studied by Bloom and colleagues (Bloom et al., 1980) . The diarrhoea fulfils the usual criteria of a secretory process since it is usually profuse, persists on fasting, and the faecal water osmolality is accounted for almost entirely by the sodium and potassium concentrations (multiplied by a factor of two). Transport mechanisms for water and ions may be abnormal in both small and large bowel.
Pancreatic-polypeptidoma (PP-oma).
There is as yet no discernible characteristic syndrome caused by this tumour, but one of three reported cases had steatorrhoea, possibly from tumour blocking the pancreatic duct (Welbourn et al., 1978) .
Gastrinoma. This paraendocrine apudoma of the pancreas produces the Zollinger-Ellison syndrome (ZES). The gastrin secreted by this tumour is carried in the general circulation to the parietal cells of the stomach which are stimulated to produce excessive amounts of hydrochloric acid. The diarrhoea in ZES results mainly from overload of the small and large bowel by both gastric acid and pancreaticobiliary alkaline secretion. However, malabsorption of water and electrolytes in the jejunum may be caused by the low intraluminal pH, patchy villous atrophy, inflammatory changes and increased plasma concentrations of gastrin. An increased clinical awareness has been the main factor in the recent trend to early diagnosis of ZES (Regan and Malagelada, 1978) and the severe complications of bleeding, perforation and fistulae, so often fatal, are now seen less frequently.
Other paraendocrine apudomas of the pancreas may rarely secrete ACTH and can lead to an acute Cushing's syndrome with its associated metabolic anormalities Qoffe et al., 1978) .
There are two non-pancreatic endocrine tumours which may cause diarrhoea, namely carcinoid tumours and medullary carcinoma of the thyroid. The carcinoid tyndrome is associated with diarrhoea which is predominantly the secretory type, but may also feature reduced colonic absorption. There is also a decreased oral-caecal transit time, probably resulting from increased motility of the small bowel. Serotonin itself may be involved in the diarrhoea, since agents which block the synthesis of serotonin or the 5-HT 2 receptors usually reduce the diarrhoea. However, the full nature of the diarrhoea has not been elucidated and other humoral mediators may be involved.
Diarrhoea occurs in one-third of the patients with medullary carcinoma of the thyroid. The pathophysiology is not fully understood, but the diarrhoea appears to be a result of a primary effect on intestinal motility.
Intestinal Diseases Coeliac disease
In this disease there is an interaction of the waterinsoluble protein moiety (gluten) of certain cereal grains with the mucosa of the small intestine. This interaction produces pathological changes in the mucosa which vary considerably in both severity and extent and thus account for the striking variability of the clinical manifestations in patients suffering from coeliac disease. However, there is actual or potential intestinal malabsorption of virtually all nutrients. If these disease is extensive, the clinical picture includes diarrhoea, weight loss and weakness. There may be severe dehydration, electrolyte depletion and even acidosis, especially in children. Malabsorption of all nutrients including fat, carbohydrate, protein, water and electrolytes increases the stool volume delivered to the colon. Bacterial action on the increased fat in the colon causes the production of hydroxy-fatty acids which act as cathartics. The diarrhoea may also be aggravated by secretion of water and electrolytes from the jejunum and impaired absorption of conjugated bile salts from the ileum. The malabsorption and weight loss is characterized by associated hyperphagia, but if the disease is severe enough anorexia may develop. Eventually, severe weight loss may be masked by fluid retention caused by hypoproteinaemia. Pancreatic exocrine deficiency may occur in addition to endocrine deficiency and diabetes. Indeed, virtually any body system may be affected by defective absorption of nutrients from the gut with the development of anaemia, osteomalacia, osteoporosis, muscle atrophy, secondary hyperparathyroidism or hypopituitarism, and neurological and dennatological diseases.
WhippU's disease
Whipple's disease is an uncommon systemic disease which invariably involves the small bowel, but can affect almost any organ. It is characterized by infiltration of the involved tissues with large glycoprotein-containing macrophages. Diarrhoea with the passage of steatorrhoeic stools is the most common gastrointestinal complaint and most of the metabolic abnormalities are related to the severity of the intestinal malabsorption. Hypokalaemia, hypocalcaemia, hypomagnesaemia and hypoalbuminaemia are all common findings. There may also be an iron deficiency anaemia, complicated in some cases by folate deficiency. In the past, the disease led inexorably to death, but in the past 20 years the discovery of rod-shaped bacilli in the diseased tissues has led to dramatic resolution of the disease by treatment with antibiotics. The diarrhoea and malabsorption disappear within a few weeks and the small bowel villous architecture returns to normal in 2 -4 months.
Inflammatory bowel disease
Crohn's disease (involving the full thickness of the wall of the small bowel or colon, or both, and ulcerative colitis (involving only the mucosa) produce similar metabolic and fluid abnormalities. The pathophysiology of metabolic abnormalities involves mainly diarrhoea, but may be complicated by fever and hypercatabolism. Colonic losses of sodium and potassium result in salt and water depletion with a reduced ECF volume and hypokalaemia. Patients receiving large doses of corticosteroids may, in addition, have excessive renal potassium losses. There is commonly an associated metabolic acidosis aggravated by colonic loss of bicarbonate and uraemia associated with the hypercatabolism. Systemic illness and anorexia lead to a low protein-calorie intake and exacerbate the hypoalbuminaemia caused by the excessive protein-losing enteropathy from the inflamed intestinal mucosa. Patients often develop iron deficiency anaemia from blood loss and there may be toxic suppression of bone marrow. Disease involving the terminal ileum produces malabsorption of bile acids, thus tending to exacerbate the diarrhoea. Similarly, there may be malabsorption of vitamin B 12 . Complications of both Crohn's disease and ulcerative colitis may cause extra metabolic and fluid disturbances. Intestinal obstruction may occur in Crohn's disease and, together with enteroenteral or entero -cutaneous fistulae, lead to further fluid and electrolyte losses. There may also be massive intestinal haemorrhage or the late development of a colonic carcinoma. Uncorrected fluid and electrolyte deficits, particularly hypokalaemia, have been incriminated in the development of toxic megacolon and renal calculi.
It is in the inflammatory bowel diseases that total parenteral nutrition has established itself as a valuable adjunct to both medical and surgical treatment. However, the treatment of these disease processes may involve the surgical formation of an ileostomy or colostomy with further implications for fluid balance and nutritional care.
